PL377664A1 - Benzoksazocyny i ich zastosowanie jako inhibitorów wychwytu zwrotnego monoamin - Google Patents

Benzoksazocyny i ich zastosowanie jako inhibitorów wychwytu zwrotnego monoamin

Info

Publication number
PL377664A1
PL377664A1 PL377664A PL37766403A PL377664A1 PL 377664 A1 PL377664 A1 PL 377664A1 PL 377664 A PL377664 A PL 377664A PL 37766403 A PL37766403 A PL 37766403A PL 377664 A1 PL377664 A1 PL 377664A1
Authority
PL
Poland
Prior art keywords
benzoxazocines
monoamine
disorders
reuptake inhibitors
emesis
Prior art date
Application number
PL377664A
Other languages
English (en)
Inventor
Andrew Douglas Baxter
Original Assignee
Arakis Ltd.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB0229743A external-priority patent/GB0229743D0/en
Priority claimed from GB0316914A external-priority patent/GB0316914D0/en
Application filed by Arakis Ltd. filed Critical Arakis Ltd.
Publication of PL377664A1 publication Critical patent/PL377664A1/pl

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D413/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/04Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/08Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00Drugs for disorders of the urinary system
    • A61P13/02Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • A61P15/08Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00Drugs for skeletal disorders
    • A61P19/02Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00Drugs for disorders of the muscular or neuromuscular system
    • A61P21/02Muscle relaxants, e.g. for tetanus or cramps
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/04Centrally acting analgesics, e.g. opioids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/06Antimigraine agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/24Antidepressants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/30Drugs for disorders of the nervous system for treating abuse or dependence
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D267/00Heterocyclic compounds containing rings of more than six members having one nitrogen atom and one oxygen atom as the only ring hetero atoms
    • C07D267/22Eight-membered rings

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Pain & Pain Management (AREA)
  • Neurosurgery (AREA)
  • Psychiatry (AREA)
  • Reproductive Health (AREA)
  • Rheumatology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Immunology (AREA)
  • Urology & Nephrology (AREA)
  • Hospice & Palliative Care (AREA)
  • Otolaryngology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Pregnancy & Childbirth (AREA)
  • Addiction (AREA)
  • Endocrinology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Control Of Motors That Do Not Use Commutators (AREA)
  • Noodles (AREA)
  • Valve-Gear Or Valve Arrangements (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
PL377664A 2002-12-20 2003-12-22 Benzoksazocyny i ich zastosowanie jako inhibitorów wychwytu zwrotnego monoamin PL377664A1 (pl)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB0229743A GB0229743D0 (en) 2002-12-20 2002-12-20 Novel benzoxazocines
GB0316914A GB0316914D0 (en) 2003-07-18 2003-07-18 Novel benzoxazocines

Publications (1)

Publication Number Publication Date
PL377664A1 true PL377664A1 (pl) 2006-02-06

Family

ID=32683980

Family Applications (1)

Application Number Title Priority Date Filing Date
PL377664A PL377664A1 (pl) 2002-12-20 2003-12-22 Benzoksazocyny i ich zastosowanie jako inhibitorów wychwytu zwrotnego monoamin

Country Status (14)

Country Link
EP (2) EP1572672B1 (pl)
JP (1) JP2006522012A (pl)
AT (1) ATE404543T1 (pl)
AU (1) AU2003295171B2 (pl)
BR (1) BR0317467A (pl)
CA (1) CA2503172A1 (pl)
DE (1) DE60322947D1 (pl)
ES (1) ES2311749T3 (pl)
MX (1) MXPA05006653A (pl)
NO (1) NO20052308L (pl)
NZ (1) NZ539488A (pl)
PL (1) PL377664A1 (pl)
PT (1) PT1572672E (pl)
WO (1) WO2004056788A1 (pl)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EA013248B1 (ru) 2002-12-20 2010-04-30 Пфайзер Продактс Инк. Производные пиримидина для лечения патологического роста клеток
JP2007533718A (ja) * 2004-04-21 2007-11-22 ソセイ・アール・アンド・ディー・リミテッド ベンゾオキサゾシン類およびそれらのモノアミン再取込み阻害剤としての治療的使用
GB0408864D0 (en) * 2004-04-21 2004-05-26 Arakis Ltd Novel benzoxazocines
GB2413322A (en) * 2004-04-21 2005-10-26 Arakis Ltd Nefopam analogues
GB0504960D0 (en) * 2005-03-10 2005-04-20 Arakis Ltd Benzoxazocines
GB0506835D0 (en) * 2005-04-04 2005-05-11 Arakis Ltd Therapeutic use of nefopam
GB0515703D0 (en) * 2005-07-29 2005-09-07 Arakis Ltd Therapeutic use of nefopam
GB0609793D0 (en) * 2006-05-17 2006-06-28 Arakis Ltd Racemisation and recycling process
JP5194607B2 (ja) * 2006-07-26 2013-05-08 大正製薬株式会社 ソーシャルインターラクションの低下予防・改善剤
US8957107B2 (en) 2009-12-15 2015-02-17 The Hospital For Sick Children Method of treating scars and β-catenin-mediated disorders using Nefopam compounds

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3830803A (en) * 1965-05-10 1974-08-20 Riker Laboratories Inc 5-loweralkyl-1-phenyl-1,3,4,6-tetrahydro-5h-benz(f)-2,5-oxazocines and 4-ones
US3978085A (en) * 1975-03-07 1976-08-31 Riker Laboratories, Inc. Process for benz[f]-2,5-oxazocines
US4166452A (en) 1976-05-03 1979-09-04 Generales Constantine D J Jr Apparatus for testing human responses to stimuli
US4256108A (en) 1977-04-07 1981-03-17 Alza Corporation Microporous-semipermeable laminated osmotic system
GB1586578A (en) * 1977-08-05 1981-03-18 Riker Laboratories Inc Process for the preparation of 2-(n-(2-hydroxyyethyl)-n-lower alkylaminomethyl) benzhydrols
US4265874A (en) 1980-04-25 1981-05-05 Alza Corporation Method of delivering drug with aid of effervescent activity generated in environment of use

Also Published As

Publication number Publication date
MXPA05006653A (es) 2005-09-30
AU2003295171B2 (en) 2007-09-06
ATE404543T1 (de) 2008-08-15
CA2503172A1 (en) 2004-07-08
ES2311749T3 (es) 2009-02-16
JP2006522012A (ja) 2006-09-28
AU2003295171A1 (en) 2004-07-14
NO20052308D0 (no) 2005-05-11
PT1572672E (pt) 2008-10-02
EP1950206A1 (en) 2008-07-30
HK1075896A1 (en) 2005-12-30
DE60322947D1 (de) 2008-09-25
EP1572672B1 (en) 2008-08-13
WO2004056788A1 (en) 2004-07-08
NO20052308L (no) 2005-09-05
BR0317467A (pt) 2005-11-16
NZ539488A (en) 2008-03-28
EP1572672A1 (en) 2005-09-14

Similar Documents

Publication Publication Date Title
RS20120158A3 (en) Phenyl-piperazine Derivatives As Serotonin Resorption Inhibitors
NO992821L (no) Ketobenzamider som calpain-inhibitorer
PT1572672E (pt) Benzoxazocinas e sua utilização como inibidores de reabsorção de monoamina
PL356402A1 (pl) Kombinacja inhibitora wychwytu zwrotnego serotoniny i antagonisty, odwracalnego agonisty lub częściowego agonisty receptora 5-HT 2C
DE60214591D1 (en) Pyrazolpyrimidinfungizide
CA2441313A1 (en) New spirotricyclic derivatives and their use as phosphodiesterase-7 inhibitors
DE60221098D1 (de) Kondensierte heterocyclische derivate
BG106912A (bg) Дифенилетерни съединения, приложими в терапията
MXPA05007754A (es) Inhibidores de polimerasa viral.
EA200600294A1 (ru) [1,8] нафтиридин-2-оны и родственные соединения для лечения шизофрении
TW200510405A (en) Bridged n-arylsulfonylpiperidines as gamma-secretase inhibitors
WO2002085896A8 (en) Antidepressant azaheterocyclylmethyl derivatives of 2,3-dihydro-1,4-benzodioxan
AR041299A1 (es) Derivados de pirrolidona como inhibidores de maob
NO20062677L (no) Benzyleteraminforbindelser anvendbare som CCR-5-antagonister
NO940163L (no) Tricyklisk kondenserte heterocykliske forbindelser, deres fremstilling og anvendelse
WO2005009392A3 (en) Dihydropyrimidone inhibitors of calcium channel function
EP1400513A4 (en) UNSYMMETRIC CYCLIC DIAMOND COMPOUND
DE69427517D1 (de) Tetracyclische kondensierte heterocyclische Verbindungen zur Behandlung von seniler Demenz
BR0209343A (pt) Antidepressivos de azaheterociclilmetila derivados de [1,4]-benzodioxanos oxaheterociclo-fundidos; métodos de tratamento usando tais compostos; processo para prepará-los
WO2004052858A3 (en) Inhibitors of monoamine uptake
DE50209441D1 (de) Triazolopyrimidine fungizide
BR0209342A (pt) Antidepressivos de azaheterociclilmetila derivados de 2,3 dihidro-1,4-dioxino[2,3-f]quinoxalina; método de tratamento usando tais compostos; processo para prepará-los
ATE304016T1 (de) Antidepressive (sssri) azaheterocyclylmethylderivate von 7,8-dihydro-3h- 6,9-dioxa-1,3-diazacyclopenta (a) naphthalin
DK1392700T3 (da) Antidepressive azaheterocyclylmethylderivater af 7,8-dihydro-1,6,9-trioxa-3-aza-cyclopenta[a]naphthalen
CO5640133A2 (es) Derivados de 4-(2-feniloxifenil)-piperidina o 1,2,3,6-tetrahidropiridina como inhibidores de la recaptacion de la serotonina

Legal Events

Date Code Title Description
REFS Decisions on refusal to grant patents (taken after the publication of the particulars of the applications)